No Evidence of Post-finasteride Syndrome in 267,983 Person-years Follow-up in the Prostate Cancer Prevention Trial. // Urology. – URL: https://www.sciencedirect.com/science/article/pii/S0090429526005297?dgcid=rss_sd_all
No Evidence of Post-finasteride Syndrome in 267,983 Person-years Follow-up in the Prostate Cancer Prevention Trial. Urology. https://www.sciencedirect.com/science/article/pii/S0090429526005297?dgcid=rss_sd_all
“No Evidence of Post-finasteride Syndrome in 267,983 Person-years Follow-up in the Prostate Cancer Prevention Trial.” Urology.
@article{article95509,
title = {No Evidence of Post-finasteride Syndrome in 267,983 Person-years Follow-up in the Prostate Cancer Prevention Trial},
journal = {Urology},
url = {https://www.sciencedirect.com/science/article/pii/S0090429526005297?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...